Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

See Cheng Yeo

ResearcherPublications, citations & collaboration network

See Cheng Yeo is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 52 works, 929 citations, an h-index of 16 and an i10-index of 19.

52
Works
929
Citations
16
h-index
19
i10-index

How has See Cheng Yeo's publication output changed over time?

ScholarIQpublication output · 2015–2024

Output grew200% over the shown period — from 1 works in 2015 to 3 in 2024.

1
1
1
1
1
2
3
2015201720192020202120232024

What are the most-cited papers on See Cheng Yeo?

ScholarIQmost cited works
New insights into the pathogenesis of IgA nephropathy
See Cheng Yeo, Chee Kay Cheung, Jonathan Barratt
Pediatric Nephrology. 2017170 CitationsOPEN ACCESS
Is immunoglobulin A nephropathy different in different ethnic populations?
See Cheng Yeo, Su Mein Goh, Jonathan Barratt
Nephrology. 201998 CitationsOPEN ACCESS
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial
Hiddo J.L. Heerspink, Rajiv Agarwal, George L. Bakris, David Z.I. Cherney, Carolyn S.P. Lam, Brendon L. Neuen, Pantelis Sarafidis, Katherine R. Tuttle, Christoph Wanner, Meike Brinker, Sara Dizayee, Peter Kolkhof, Patrick Schloemer, Paula Vesterinen, Vlado Perkovic, for the FIND-CKD investigators, Julio Bittar, Cesar Javier Zaidman, Natalia Cluigt, Miguel Hominal, Paola Aguerre, Fernando Halac, Elizabeth Gelersztein, M. Arriola, Rafaël Maldonado, Mariano Chahin, David Packham, Darren J. Lee, Eugenia Pedagogos, Celine Foote, Sunil V. Badve, Carmel M. Hawley, Jenny Chen, Nicholas A. Gray, Marijn M. Speeckaert, Laura Labriola, Peter Doubel, Bart Maes, Kathleen Claes, Bernard Dubois, Irena Dimitrova, Tsvetelina Vutova, Stefan Ilchev, Svetla Stamova, Yordanka Ivanova, А М Васильева, Xiangmei Chen, Shuifu Tang, Xudong Xu, Bi‐Cheng Liu, Weiming He, Yani He, Fang Liu, Caili Wang, Lianhua Chen, Jianying Niu, Deguang Wang, Ping Luo, Yuou Xia, Gengru Jiang, Qun Luo, Fang Wang, Menghua Chen, Hongli Lin, Rui Yan, Yinan Li, Qinkai Chen, Junwu Dong, Fei Xiong, Haibo Long, Hong Cheng, Yuehong Li, Juan Du, Fanna Liu, Qingping Chen, Wanhong Lu, Chaosheng Chen, Jianqin Wang, Lei Liu, Min Yang, Gang Long, Yongjun Shi, Wenge Li, Xiangdong Yang, Aicheng Yang, Jianfei Li, Xiaoyan Meng, Martin Prázný, Lucie Hornova, Petr Bucek, Mária Majerníková, Jan Wirth, Jitka Řehořová, Mads Hornum, Jesper Nørgaard Bech, Morten Lindhardt, Ditte Hansen, Line Mortensen, Claus Bogh Juhl, Ioannis Boletis
Nephrology Dialysis Transplantation. 202482 CitationsOPEN ACCESS
Cost-effectiveness of screening for chronic kidney disease in the general adult population: a systematic review
See Cheng Yeo, Hankun Wang, Gary Yee Ang, Chee Kong Lim, Xin Yi Ooi
Clinical Kidney Journal. 202375 CitationsOPEN ACCESS
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial
Jonathan Barratt, Adrian Liew, See Cheng Yeo, Anders Fernström, Sean J. Barbour, C. John Sperati, Russell Villanueva, Ming‐Ju Wu, Dazhe Wang, Anna Borodovsky, Prajakta Badri, Elena Yureneva, Ishir Bhan, Daniel Cattran, on behalf of the Cemdisiran Phase 2 Study Investigators and Collaborators
Clinical Journal of the American Society of Nephrology. 202469 CitationsOPEN ACCESS

Related on ScholarIQ

University of Leicester
Institution
New insights into the pathogenesis of IgA nephropathy
Paper
Is immunoglobulin A nephropathy different in different ethnic populations?
Paper
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial
Paper
Cost-effectiveness of screening for chronic kidney disease in the general adult population: a systematic review
Paper
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial
Paper
470M+ articles · free account